Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots Using Lanthanide-Based Immunofluorescence Analysis “17α-OH-PROGESTERONE-NEOSCREEN” (TU 9398-038-49941990-2009)

Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots Using Lanthanide-Based Immunofluorescence Analysis “17α-OH-PROGESTERONE-NEOSCREEN” (TU 9398-038-49941990-2009)

Reagent kit designed for the quantitative measurement of 17α-hydroxyprogesterone in dried blood spots using lanthanide-based immunofluorescence analysis.

The “17α-OH-PROGESTERONE-NEOSCREEN” kit is manufactured in accordance with technical specifications TU 9398-038-49941990-2009 and is intended for laboratory diagnostic use.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots Using Lanthanide-Based Immunofluorescence Analysis “17α-OH-PROGESTERONE-NEOSCREEN” (TU 9398-038-49941990-2009), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.